Dillon & Associates Inc. Decreases Stock Holdings in Celsius Holdings Inc. (NASDAQ:CELH)

Key Points

• Dillon & Associates Inc. has reduced its stake in Celsius Holdings Inc. by 53.5% during the first quarter, selling 36,950 shares and now holding 32,177 shares valued at $1,158,000.
• Celsius Holdings received multiple analyst upgrades, with TD Cowen and JPMorgan Chase raising their price targets to $55.00 and $54.00, respectively, indicating strong analyst confidence despite fluctuations in the stock price.
• The company reported impressive earnings, with $0.47 EPS, significantly above the consensus estimate of $0.23, and its revenue surged by 83.9% year-over-year to $739.3 million.

Dillon & Associates Inc. reduced its position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 53.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,177 shares of the company's stock after selling 36,950 shares during the period. Dillon & Associates Inc.'s holdings in Celsius were worth $1,158,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Independent Advisor Alliance purchased a new stake in shares of Celsius during the 1st quarter worth $354,000. Nuveen LLC acquired a new stake in Celsius during the 1st quarter worth $17,223,000. Invesco Ltd. raised its stake in Celsius by 1.8% during the 1st quarter. Invesco Ltd. now owns 2,394,811 shares of the company's stock worth $85,303,000 after acquiring an additional 42,997 shares in the last quarter. Mizuho Markets Americas LLC acquired a new stake in Celsius during the 1st quarter worth $3,057,000. Finally, Cynosure Group LLC raised its stake in Celsius by 24.2% during the 1st quarter. Cynosure Group LLC now owns 26,155 shares of the company's stock worth $932,000 after acquiring an additional 5,095 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CELH has been the topic of several research analyst reports. TD Cowen upgraded shares of Celsius from a "hold" rating to a "buy" rating and lifted their price target for the stock from $37.00 to $55.00 in a research note on Monday, June 16th. Bank of America lifted their price target on shares of Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research note on Friday. JPMorgan Chase & Co. lifted their price target on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a research note on Thursday, July 31st. Needham & Company LLC lifted their price target on shares of Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a research note on Thursday. Finally, Maxim Group lifted their price target on shares of Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $51.72.

Celsius Stock Performance

Shares of CELH opened at $51.95 on Monday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The company has a market capitalization of $13.39 billion, a price-to-earnings ratio of 140.41, a PEG ratio of 1.80 and a beta of 1.40. The company's 50 day simple moving average is $44.51 and its 200 day simple moving average is $36.21. Celsius Holdings Inc. has a 1 year low of $21.10 and a 1 year high of $53.85.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same quarter in the prior year, the firm posted $0.28 earnings per share. The company's quarterly revenue was up 83.9% compared to the same quarter last year. On average, sell-side analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current year.

Insider Buying and Selling

In related news, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the completion of the transaction, the insider owned 18,017,770 shares of the company's stock, valued at approximately $851,699,987.90. This represents a 1.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO John Fieldly sold 143,167 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the completion of the sale, the chief executive officer directly owned 895,410 shares of the company's stock, valued at $45,827,083.80. The trade was a 13.78% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,106,141 shares of company stock valued at $51,985,705. Insiders own 2.20% of the company's stock.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.